Drug Type Synthetic peptide |
Synonyms erepdekinra |
Target |
Mechanism IL-17RA antagonists(Interleukin-17 receptor A antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC88H130N22O22 |
InChIKeyYIXJTJKQQNLLRJ-FGAVTVSPSA-N |
CAS Registry2641313-47-3 |